EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Multifaceted Role of miR-21 in Pancreatic Cancers

Clare Chen, Lusine Demirkhanyan, Christopher S Gondi

Cells · 30.05.2024 · 13 (11) · 948

DOI: 10.3390/cells13110948 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 30.05.2024. Verfasst von Clare Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the lack of specific signs and symptoms, pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at late metastatic stages, resulting in poor survival outcomes. Among various biomarkers, microRNA-21 (miR-21), a small non-coding RNA, is highly expressed in PDAC. By inhibiting regulatory proteins at the 3′ untranslated regions (UTR), miR-21 holds significant roles in PDAC cell proliferation, epithelial–mesenchymal transition, angiogenesis, as well as cancer invasion, metastasis, and resistance therapy. We conducted a systematic search across major databases for articles on miR-21 and pancreatic cancer mainly published within the last decade, focusing on their diagnostic, prognostic, therapeutic, and biological roles. This rigorous approach ensured a comprehensive review of miR-21’s multifaceted role in pancreatic cancers. In this review, we explore the current understandings and future directions regarding the regulation, diagnostic, prognostic, and therapeutic potential of targeting miR-21 in PDAC. This exhaustive review discusses the involvement of miR-21 in proliferation, epithelial–mesenchymal transition (EMT), apoptosis modulation, angiogenesis, and its role in therapy resistance. Also discussed in the review is the interplay between various molecular pathways that contribute to tumor progression, with specific reference to pancreatic ductal adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPancreatic NeoplasmsEpithelial-Mesenchymal TransitionHumansCarcinoma, Pancreatic DuctalGene Expression Regulation, NeoplasticCell ProliferationApoptosisAnimalsNeovascularization, PathologicBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

epithelial–mesenchymal transition (EMT)miR-21pancreatic ductal adenocarcinomaproliferationsmall non-coding RNA

Substanzen

MicroRNAsMIRN21 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Departments of Internal Medicine and Surgery, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Departments of Internal Medicine, Surgery, and Health Science Education and Pathology, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA.
  • Health Care Engineering Systems Center, The Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Zitieren

APA

Chen, C., Demirkhanyan, L., & Gondi, C. S. (2024). The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells, 13(11), 948. https://doi.org/10.3390/cells13110948

Vancouver

Chen C, Demirkhanyan L, Gondi CS. The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells. 2024;13(11):948. doi:10.3390/cells13110948

BibTeX
@article{Chen2024,
  author = {Chen, Clare and Demirkhanyan, Lusine and Gondi, Christopher S},
  title = {The Multifaceted Role of miR-21 in Pancreatic Cancers},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {948},
  doi = {10.3390/cells13110948}
}
Kostenlos starten →